PhysiciansProtect your patients and your practice with the know error® system The biopsy evaluation process requires a number of steps and several medical professionals. Each year, it plays a critical role in determining the diagnoses and treatments of millions of patients. With such a complex process executed at such a large scale, physicians and patients need an effective way to prevent diagnostic mistakes due to Specimen Provenance Errors (SPE)About Specimen Provenance Errors (SPE) Launched in the spring of 2009, the know error® system for prostate biopsies represents an important innovation in the process of evaluating biopsies, providing physicians with an added measure of patient safety and diagnostic accuracy. Through the use of bar code technology and forensic DNA testing, the system virtually eliminates the possibility that Specimen Provenance Errors (SPE) will result in adverse patient outcomes. In his endorsement of the know error® system, Dr. Peter M. Knapp, Jr. explains how the system has changed the biopsy evaluation process for his practice: “It [the know error® system] provides one more independent set of checks and balances to protect our patients, our physicians, and our laboratory from the potentially devastating effects of undetected specimen switching errors. Guided by this independent verification of sample identity, my partners and I can recommend therapy to patients with the increased confidence that can only come from a positive DNA match between the patient and his pathology tissue. Having become accustomed to this added measure of confidence, it is difficult now to imagine initiating treatment without it.” Find out more about the know error® system, how DNA verification works, and why it is an important part of the biopsy evaluation process by clicking on one of the following links:
If you would like more information about the know error® system, click here to contact us. |